Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-28

FDA Approved: POSACONAZOLE — Original Application (i3 Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved an original application for posaconazole from i3 Pharmaceuticals, LLC (generic posaconazole).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POSACONAZOLE (POSACONAZOLE)

Snippet

ORIG AP for POSACONAZOLE (POSACONAZOLE)